BIOADAPTIVES, INC.

Insiders BioAdaptives, Inc.

Equities

BDPT

US09072U1079

Delayed OTC Markets Other stock markets 10:50:33 2024-05-13 am EDT			5-day change	1st Jan Change
0.0005 ^USD	0.00%		0.00%	0.00%

Apr. 10	BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 22	Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioAdaptives, Inc. Announces the Appointment of David Allen to its Board of Directors	23-04-13	CI
BioAdaptives, Inc. Announces the Appointment of Dr. Yaguang Liu to its Board of Directors	23-04-05	CI
Bioadaptives, Inc Appoints Charles Townsend as Chief Operating Officer and as A Director	21-06-10	CI
BioAdaptives, Inc. Announces Tizhemp, a New Hemp-Product Division; Appoints Ron Lambrecht as New CFO	19-09-24	CI
BioAdaptives, Inc. Appoints Robert W. Ellis as New President	19-09-10	CI
BioAdaptives, Inc Names Dr. James Rouse as President and Board Member	18-05-15	CI
BioAdaptives, Inc. Announces Management Changes	18-03-15	CI
BioAdaptives Appoints Christopher G. Hall as President, with Additional Titles of Chief Executive Officer, Chief Financial Officer, and Secretary	15-02-06	CI
BioAdaptives, Inc. Appoints Barry Epling as President and CEO	14-07-14	CI
APEX 8 Inc. has Changed its Name to BioAdaptives, Inc	13-09-30	CI
APEX 8 Inc. Announces Management Changes	13-07-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW